ClinicalTrials.Veeva

Menu
I

Instituto de Investigaciones Aplicadas a la Neurociencia A.C. | Durango, Mexico

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Vedolizumab
Ontamalimab
Lurasidone
Fingolimod
MNK-1411
Losartan
Ocrelizumab
Cobitolimod
Avelumab
Baricitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 25 total trials

A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)

This Phase III study is a global multicenter, randomized, double-blind,placebo controlled clinical trial to evaluate the efficacy, safety, and immuno...

Active, not recruiting
COVID-19
Other: Placebo control
Biological: Recombinant COVID-19 vaccine (Sf9 cells)
Locations recently updated

The reason for this study is to see if the study drug called baricitinib works and is safe in children and teenage participants with atopic dermatiti...

Active, not recruiting
Atopic Dermatitis
Drug: Topical corticosteroid
Drug: Baricitinib

This double-blind, double-dummy study will evaluate the safety and efficacy of ocrelizumab compared with fingolimod in children and adolescents with...

Enrolling
Relapsing-Remitting Multiple Sclerosis
Other: Ocrelizumab Placebo
Drug: Ocrelizumab

This study aims to evaluate the safety and tolerability of clesrovimab compared to palivizumab as assessed by the proportion of participants experien...

Active, not recruiting
RSV Infection
Biological: Placebo
Biological: Palivizumab

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent...

Enrolling
Overweight and Obesity
Drug: Retatrutide
Drug: Placebo

Trial sponsors

Shire logo
Takeda logo
Lilly logo
M
Roche logo
Sumitomo Pharma logo
A
I
I
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems